| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |